ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. It provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. It provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide. It also offers IRRAflow active fluid-exchange system.
Company Information
About this company
Key people
Joseph Michael Burnett
President, Chief Executive Officer, Director
Danilo D' Alessandro
Chief Financial Officer
Mazin Sabra
Chief Operating Officer
Jeremy L. Stigall
Chief Business Officer
R. John Fletcher
Independent Chairman of the Board
Lynnette C. Fallon
Independent Director
Pascal E.R. Girin
Independent Director
B. Kristine Olson Johnson
Independent Director
Matthew B. Klein
Independent Director
Click to see more
Key facts
- Shares in issue29.75m
- EPICCLPT
- ISINUS18507C1036
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$395.95m
- Employees115
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.